Ren Yang
Beijing, 102629, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Rapid LC-MS Quantification of mRNA Vaccine Capping Efficiency via High-Specificity RNase H Cleavage and Metal Adduct Suppressed Chromatography.
Journal: Vaccines
Published: May 16, 2026
A SARS-CoV-2 EG.5 mRNA vaccine induces a broad-spectrum immune response in mice.
Journal: MedComm
Published: April 11, 2024
An mRNA vaccine against rabies provides strong and durable protection in mice.
Journal: Frontiers in immunology
Published: September 05, 2023
The recombinant truncated envelope protein of West Nile virus adjuvanted with Alum/CpG induces potent humoral and T cell immunity in mice.
Journal: Biosafety and health
Published: March 16, 2023
DNA Vaccines Expressing the Envelope and Membrane Proteins Provide Partial Protection Against SARS-CoV-2 in Mice.
Journal: Frontiers in immunology
Published: December 02, 2021
SARS-CoV-2-specific T cell immunity to structural proteins in inactivated COVID-19 vaccine recipients.
Journal: Cellular & molecular immunology
Published: June 06, 2021
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity.
Journal: Signal transduction and targeted therapy
Published: March 10, 2021
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.
Journal: Emerging microbes & infections
Published: September 07, 2020
Comparative Transcriptome Analysis Reveals the Intensive Early Stage Responses of Host Cells to SARS-CoV-2 Infection.
Journal: Frontiers in microbiology
Published: August 11, 2020
Development and effectiveness of pseudotyped SARS-CoV-2 system as determined by neutralizing efficiency and entry inhibition test in vitro.
Journal: Biosafety and health
Published: May 06, 2020
Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections.
Journal: EBioMedicine
Published: April 15, 2020
Neutralizing Antibody Titer Test of Ebola Recombinant Protein Vaccine and Gene Vector Vaccine pVR-GP-FC.
Journal: Biomedical and environmental sciences : BES
Published: August 09, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026